- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A dermatologist alleged a Ranbaxy letter implied Co-Cyprindiol contained isotretinoin and erythromycin. The Panel found no breach of Clause 7.2, but said…
Anonymous GP alleged a representative’s venue ownership, free drinks and sports team sponsorship created conflicts and inducement. Panel found concerns about perception…
A Times diabetes supplement funded and editorially controlled by Novo Nordisk included trial claims about unapproved liraglutide. The PMCPA ruled it promoted…
Genus alleged Stiefel offered a PCT a cash rebate if Oilatum was reinstated on formulary (inducement to prescribe). Accounts conflicted and evidence…
Anonymous GP alleged an osteoporosis audit pushed Adcal-D3. Panel found no inducement or product-link evidence, but ruled two breaches for poor standards:…
Roche ran a CF adherence programme offering £10 high-street vouchers to children/teens for returning Pulmozyme ampoule caps. PMCPA ruled it could prompt…
A GP and pharmacist said a GP journal acne management insert was disguised promotion for Duac. After a procedural error in an…
A pharmacist alleged an oncology team dinner was purely social. PMCPA found the three-course meal with wine went beyond subsistence and was…
Leo promoted Innohep as “long-term” therapy for VTE in cancer patients. Panel found no breach, but on appeal the Appeal Board ruled…
Pentasa abbreviated ad in a UK conference programme was placed by Swiss global marketing without UK certification. Claims were inconsistent with SPC,…
Ex-employee challenged legibility of prescribing information in BMJ ads for Seroquel XL, Zoladex and Crestor. Panel found Seroquel XL PI not clear…
ProStrakan’s Abstral BMJ ad claimed “Acts in minutes” and “To hell and back in minutes”, implying onset faster than the SPC’s 15…
Resolor promo used “At last! A new way out of chronic constipation in women”. Appeal Board found no breach for folder/drop card…
Lilly’s Diabetes UK “satellite symposium” was ruled promotional, leading to pre-licence promotion findings for exenatide once-weekly (LAR) and misleading exhibition claims about…
Otsuka Europe circulated confusing SPC implementation timelines and certified/distributed incorrect Jinarc prescribing information inconsistent with the SPC. Appeal Board ruled cumulative failings…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.